Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| VAXGEN INC | 22,000 | reported | 16 Nov 2007 | tx 2+45,000 |
| SCOLR Pharma, Inc. | 17,500 | reported | 11 Jun 2009 | tx 8+132,500−89,526 |
| SBE INC | 13,750 | reported | 12 Mar 2004 | tx 1−5,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Jun 2009 | GRANT_AWARD | SCOLR Pharma, Inc. | 17,500 | 0.00 USD | deriv |
| 05 Jun 2008 | GRANT_AWARD | SCOLR Pharma, Inc. | 17,500 | 0.00 USD | deriv |
| 11 Mar 2008 | EXERCISE | SCOLR Pharma, Inc. | 50,000 | 1.00 USD | |
| 11 Mar 2008 | SALE | SCOLR Pharma, Inc. | 39,526 | 1.00 USD | |
| 11 Mar 2008 | EXERCISE | SCOLR Pharma, Inc. | 50,000 | — | deriv |
| 16 Nov 2007 | PURCHASE | VAXGEN INC | 10,000 | 0.65 USD | first after silence |
| 07 Jun 2007 | GRANT_AWARD | SCOLR Pharma, Inc. | 17,500 | — | deriv |
| 12 Feb 2007 | GRANT_AWARD | VAXGEN INC | 35,000 | 0.00 USD | deriv |
| 03 Jan 2006 | GRANT_AWARD | SCOLR Pharma, Inc. | 25,000 | — | deriv |
| 18 Aug 2004 | PURCHASE | SCOLR Pharma, Inc. | 5,000 | 1.81 USD | |
| 12 Mar 2004 | EXERCISE | SBE INC | 5,000 | 5.41 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 16 Nov 2007.